An official website of the United States government
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Trial Status: active
Multi-center, prospective non-interventional study to collect data on the early use of
Adstiladrin in the US and Israel. Data will be collected from patients and prescribing
physicians in a real-world setting
Inclusion Criteria
Prescribed and scheduled treatment with ADSTILADRIN per physician discretion or received the first instillation of ADSTILADRIN per physician discretion after 5 September 2023 but prior to site activation
Signed and dated ICF.
Age 18 years or older at day ICF is signed.
Exclusion Criteria
Currently enrolled in a clinical trial.
Participants who have previously been treated with ADSTILADRIN in the context of a clinical trial
Participant is pregnant or breastfeeding.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06026332.
Locations matching your search criteria
United States
Arizona
Scottsdale
Mayo Clinic in Arizona
Status: Active
Name Not Available
Florida
Jacksonville
Mayo Clinic in Florida
Status: Active
Name Not Available
Georgia
Atlanta
Emory University Hospital/Winship Cancer Institute
Status: Active
Name Not Available
Maryland
Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center
Status: Active
Name Not Available
Minnesota
Rochester
Mayo Clinic in Rochester
Status: Active
Name Not Available
New York
New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
